Bile salt exposure causes phosphatidylinositol-3-kinase-mediated proliferation in a Barrett's adenocarcinoma cell line

被引:31
作者
Jaiswal, K
Tello, V
Lopez-Guzman, C
Nwariaku, F
Anthony, T
Sarosi, GA
机构
[1] Dallas VA Med Ctr, Surg Serv, Dallas, TX 75216 USA
[2] Univ Texas, SW Med Ctr, Dallas, TX 75216 USA
关键词
D O I
10.1016/j.surg.2004.04.008
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. The mechanisms by which gastroesophageal reflux promotes malignant progression in Barrett's esophagus are poorly understood. The phosphatidylinositol-3-kinase (PI3 kinase)/Akt pathway regulates proliferation and apoptosis. We hypothesized that the PI3 kinase/Akt pathway mediates the pro-Proliferative and antiapoptotic effects of bile. Methods. The Barrett's adenocarcinoma cell line, SEG-1, was exposed to the conjugated bile salt, glycochenodeoxycholic acid (GCDA). Cell number was measured by the MTT incorporation assay and by Coulter counter. PI3 kinase/Akt activity was inferred from, Western blots of phosphorylated and total Akt. Proliferation and apoptosis were determined by BrdU incorporation and cell death ELISA. Results. A dose-dependent cell number increase was seen with a 20-minute exposure to GCDA. On Western blot, 200 mumol/L GCDA caused a 3-fold increase in Akt phosphorylation within 20 minutes, which was inhibited by 90% with the addition of PI3 kinase inhibitor, LY294002. LY294002 produced dose-dependent inhibition of GCDA-induced cell number increases. 200 mumol/L GCDA decreased apoptosis by 25%. Addition of LY294002 did not completely inhibit the antiapoptotic effect of bile. Conclusions. Bile salts activate the PI3 kinase/Akt signaling pathway and stimulate cell growth in SEG-1. The majority of this PI3 kinase-mediated effect is secondary to increases in proliferation rather than to decreases in apoptosis.
引用
收藏
页码:160 / 168
页数:9
相关论文
共 25 条
  • [1] Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a phosphatidylinositol 3-kinase-dependent pathway in rats
    Alpini, G
    Glaser, S
    Alvaro, D
    Ueno, Y
    Marzioni, M
    Francis, H
    Baiocchi, L
    Stati, T
    Barbaro, B
    Phinizy, JL
    Mauldin, J
    LeSage, G
    [J]. GASTROENTEROLOGY, 2002, 123 (04) : 1226 - 1237
  • [2] A specific function for phosphatidylinositol 3-kinase α (p85α-p110α) in cell survival and for phosphatidylinositol 3-kinase β (p85α-p110β) in de novo DNA synthesis of human colon carcinoma cells
    Bénistant, C
    Chapuis, H
    Roche, S
    [J]. ONCOGENE, 2000, 19 (44) : 5083 - 5090
  • [3] Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy
    Chang, F
    Lee, JT
    Navolanic, PM
    Steelman, LS
    Shelton, JG
    Blalock, WL
    Franklin, RA
    McCubrey, JA
    [J]. LEUKEMIA, 2003, 17 (03) : 590 - 603
  • [4] Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.3.CO
  • [5] 2-U
  • [6] Acid- and bile-induced PGE2 release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-ε dependent
    Kaur, BS
    Triadafilopoulos, G
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2002, 283 (02): : G327 - G334
  • [7] Bile salts induce or blunt cell proliferation in Barrett's esophagus in an acid-dependent fashion
    Kaur, BS
    Ouatu-Lascar, R
    Omary, MB
    Triadafilopoulos, G
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2000, 278 (06): : G1000 - G1009
  • [8] Phosphoinositide 3-kinase-dependent Ras activation by tauroursodesoxycholate in rat liver
    Kurz, AK
    Block, C
    Graf, D
    vom Dahl, S
    Schliess, F
    Häussinger, D
    [J]. BIOCHEMICAL JOURNAL, 2000, 350 : 207 - 213
  • [9] Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
    Lagergren, J
    Bergström, R
    Lindgren, A
    Nyrén, O
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (11) : 825 - 831
  • [10] Effects of deoxycholate on human colon cancer cells: apoptosis or proliferation
    Milovic, V
    Teller, IC
    Faust, D
    Caspary, WF
    Stein, J
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 (01) : 29 - 34